Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis

5 823

Cited 44 times in

Authors: Hae-Seong Nam ; Won-Jung Koh ; O. Jung Kwon ; Sang-Nae Cho ; Tae Sun Shim

Citation: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, Vol.33(1) : 92-93, 2009

MeSH: Acetamides/administration & dosage* ; Acetamides/adverse effects ; Acetamides/pharmacology ; Acetamides/therapeutic use ; Adult ; Anti-Infective Agents/administration & dosage* ; Anti-Infective Agents/adverse effects ; Anti-Infective Agents/pharmacology ; Anti-Infective Agents/therapeutic use ; Culture Media ; Drug Administration Schedule ; Drug Resistance, Multiple, Bacterial ; Extensively Drug-Resistant Tuberculosis/drug therapy* ; Extensively Drug-Resistant Tuberculosis/microbiology ; Female ; Humans ; Korea ; Linezolid ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Mycobacterium tuberculosis/drug effects* ; Mycobacterium tuberculosis/isolation & purification ; Oxazolidinones/administration & dosage* ; Oxazolidinones/adverse effects ; Oxazolidinones/pharmacology ; Oxazolidinones/therapeutic use ; Sputum/microbiology ; Treatment Outcome ; Tuberculosis, Multidrug-Resistant/drug therapy* ; Tuberculosis, Multidrug-Resistant/microbiology ; Young Adult

Full Text: http://www.sciencedirect.com/science/article/pii/S0924857908002847

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Microbiology (미생물학교실) > 1. Journal Papers

Show full item record Find it @ YMLIB

YUHSpace: Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis